EARNEST Partners’s Teva Pharmaceuticals TEVA Stock Holding History

EARNEST Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-143	Closed	-$1.46K	–	1000
2023 Q3	$1.46K	Hold	143	–	–	﹤0.01%	1030
2023 Q2	$1.08K	Hold	143	–	–	﹤0.01%	1066
2023 Q1	$1.27K	Hold	143	–	–	﹤0.01%	1041
2022 Q4	$1.3K	Hold	143	–	–	﹤0.01%	1047
2022 Q3	$1K	Hold	143	–	–	﹤0.01%	1089
2022 Q2	$1K	Hold	143	–	–	﹤0.01%	1108
2022 Q1	$1K	Hold	143	–	–	﹤0.01%	1117
2021 Q4	$1K	Hold	143	–	–	﹤0.01%	1134
2021 Q3	$1K	Hold	143	–	–	﹤0.01%	1138
2021 Q2	$1K	Hold	143	–	–	﹤0.01%	1144
2021 Q1	$2K	Hold	143	–	–	﹤0.01%	1063
2020 Q4	$1K	Hold	143	–	–	﹤0.01%	1145
2020 Q3	$1K	Hold	143	–	–	﹤0.01%	1109
2020 Q2	$2K	Hold	143	–	–	﹤0.01%	967
2020 Q1	$1K	Hold	143	–	–	﹤0.01%	1048
2019 Q4	$1K	Hold	143	–	–	﹤0.01%	1129
2019 Q3	$1K	Hold	143	–	–	﹤0.01%	1118
2019 Q2	$1K	Hold	143	–	–	﹤0.01%	1133
2019 Q1	$2K	Hold	143	–	–	﹤0.01%	1033
2018 Q4	$2K	Hold	143	–	–	﹤0.01%	1005
2018 Q3	$3K	Hold	143	–	–	﹤0.01%	967
2018 Q2	$3K	Hold	143	–	–	﹤0.01%	966
2018 Q1	$2K	Hold	143	–	–	﹤0.01%	1025
2017 Q4	$3K	Buy	+143	New	+$3K	﹤0.01%	934
2017 Q3	–	Sell	-2,992,743	Closed	-$99.4M	–	232
2017 Q2	$99.4M	Buy	2,992,743 +847,451	+40%	+$28.2M	1.04%	23
2017 Q1	$68.8M	Sell	2,145,292 -17,449	-0.8%	-$560K	0.73%	49
2016 Q4	$78.4M	Sell	2,162,741 -29,474	-1%	-$1.07M	0.86%	38
2016 Q3	$101M	Sell	2,192,215 -83,968	-4%	-$3.86M	1.06%	23
2016 Q2	$114M	Buy	2,276,183 +618,071	+37%	+$31M	1.24%	17
2016 Q1	$88.7M	Buy	1,658,112 +9,194	+0.6%	+$492K	0.93%	27
2015 Q4	$108M	Buy	1,648,918 +55,976	+4%	+$3.67M	1.1%	19
2015 Q3	$89.9M	Buy	+1,592,942	New	+$89.9M	0.88%	35
2014 Q1	–	Sell	-4,621	Closed	-$185K	–	413
2013 Q4	$185K	Buy	+4,621	New	+$185K	﹤0.01%	226